National Research Corporation

General ticker "NRC" information:

  • Sector: Health Care
  • Industry: Medical - Healthcare Information Services
  • Capitalization: $345.4M (TTM average)

National Research Corporation follows the US Stock Market performance with the rate: 33.8%.

Estimated limits based on current volatility of 2.8%: low 17.15$, high 18.14$

Factors to consider:

  • Earnings expected soon, date: 2026-04-28 bmo
  • Company pays dividends (quarterly): last record date 2026-03-27, amount 0.16$ (Y3.55%)
  • Total employees count: 368 (-15.4%) as of 2024
  • US accounted for 100.0% of revenue in the fiscal year ended 2024-12-31
  • Top business risk factors: Loss of major customers, Market competition, Pandemic risks, Vendor dependency, Regulatory and compliance
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [14.00$, 23.79$]
  • 2026-12-31 to 2027-12-31 estimated range: [13.81$, 23.63$]

Similar symbols

Short-term NRC quotes

Long-term NRC plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $148.58MM $143.06MM $137.39MM
Operating Expenses $108.53MM $107.87MM $114.80MM
Operating Income $40.05MM $35.19MM $22.59MM
Non-Operating Income $-0.08MM $-2.50MM $-4.75MM
Interest Expense $0.86MM $2.60MM $4.76MM
Income(Loss) $39.96MM $32.69MM $17.84MM
Taxes $8.99MM $7.91MM $6.24MM
Profit(Loss)* $30.97MM $24.78MM $11.60MM
Stockholders Equity $48.95MM $31.28MM $13.99MM
Assets $122.44MM $132.54MM $134.88MM
Operating Cash Flow $38.11MM $34.62MM $26.45MM
Capital expenditure $15.78MM $15.45MM $10.71MM
Investing Cash Flow $-15.78MM $-20.28MM $-10.71MM
Financing Cash Flow $-40.71MM $-16.76MM $-15.84MM
Earnings Per Share** $1.26 $1.04 $0.52

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.